Faculty

Steve Schwartz

Professor, Epidemiology

206-685-1799
stevesch@uw.edu

Education

PhD Epidemiology, University of Washington, 1990
MPH Epidemiology, Yale University, 1984

Contact

206-685-1799
stevesch@uw.edu

University of Washington
Box 351619
Department of Epidemiology
Hans Rosling Center for Population Health, 861B
Seattle, WA 98195

Research Areas

Research Interests

Dr. Schwartz primarily studies the etiology and outcomes of cancer. A major objective of his research is to determine the influence of genetic susceptibility, either alone or in combination with lifestyle and environmental risk factors. Current funded research projects include studies focusing on the genetic and non-genetic risk factors for HPV-cancers and testicular germ cell tumors. Other areas of cancer research focus on molecular markers for oral cancer outcomes and the health and well-being of adolescent and young adult cancer survivors. Among his other responsibilities in the field of cancer epidemiology, he serves as Principal Investigator of the Cancer Surveillance System, a population-based cancer registry at the Fred Hutchinson Cancer Research Center.

Recent Publications (PubMed)

Impact on the Volume of Pathology Reports Before and During the COVID-19 Pandemic in SEER Cancer Registries.
(2023 Aug 18)
Cancer Epidemiol Biomarkers Prev
Chtourou A, Sanchez PV, Golden T, Chen HS, Schwartz SM, Wu XC, Hernandez BY, Harrison JN, Penberthy L, Negoita S
Use of the Decipher genomic classifier among men with prostate cancer in the United States.
(2023 Aug 31)
JNCI Cancer Spectr 7(5):
Zaorsky NG, Proudfoot JA, Jia AY, Zuhour R, Vince R Jr, Liu Y, Zhao X, Hu J, Schussler NC, Stevens JL, Bentler S, Cress RD, Doherty JA, Durbin EB, Gershman S, Cheng I, Gonsalves L, Hernandez BY, Liu L, Morawski BM, Schymura M, Schwartz SM, Ward KC, Wiggins C, Wu XC, Shoag JE, Ponsky L, Dal Pra A, Schaeffer EM, Ross AE, Sun Y, Davicioni E, Petkov V, Spratt DE
31-Gene Expression Profile Testing in Cutaneous Melanoma and Survival Outcomes in a Population-Based Analysis: A SEER Collaboration.
(2023 Jun)
JCO Precis Oncol 7(): e2300044
Bailey CN, Martin BJ, Petkov VI, Schussler NC, Stevens JL, Bentler S, Cress RD, Doherty JA, Durbin EB, Gomez SL, Gonsalves L, Hernandez BY, Liu L, Morawski BM, Schymura MJ, Schwartz SM, Ward KC, Wiggins C, Wu XC, Goldberg MS, Siegel JJ, Cook RW, Covington KR, Kurley SJ
A masked, placebo-controlled, randomized clinical trial evaluating safety and the effect on cardiac function of low-dose rapamycin in 17 healthy client-owned dogs.
(2023)
Front Vet Sci 10(): 1168711
Barnett BG, Wesselowski SR, Gordon SG, Saunders AB, Promislow DEL, Schwartz SM, Chou L, Evans JB, Kaeberlein M, Creevy KE
Author Correction: Evaluation of cognitive function in the Dog Aging Project: associations with baseline canine characteristics.
(2023 May 30)
Sci Rep 13(1): 8753
Yarborough S, Fitzpatrick A, Schwartz SM, Dog Aging Project Consortium
Show complete publication list